Evotec
Designing and applying innovative technologies to dramatically expand global access to biotherapeutics.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Evotec. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 599 people
- Headquarters
- Seattle, WA +2 more
- Founded
- 2014
- Type
- Public Company
- Total funding
- $162.6M
Just – Evotec Biologics, a wholly owned subsidiary of Evotec SE, is an innovative and trusted CDMO for complex biologics, incl. mAbs, bi/multispecifics, and biosimilars. We provide our partners with highly differentiated services for the development and manufacturing of biologics. Our world-leading AI-driven in silico molecular optimization and continuous bioprocessing platforms combined with our revolutionary J.POD® facilities, which represent a paradigm shift within the industry, are helping to reduce the cost of goods and expand global access to affordable, high-quality biotherapeutics in addition to providing a highly agile cGMP manufacturing strategy to support rapid ramp up and uncertain demand scenarios.